Rapid Screening of ASXL1, IDH1, IDH2, and c-CBL Mutations in de Novo Acute Myeloid Leukemia by High-Resolution Melting (vol 14, pg 594, 2012)

被引：0
|
作者：
Ibanez, M.
机构：
来源：
JOURNAL OF MOLECULAR DIAGNOSTICS | 2013年 / 15卷 / 02期
关键词：
D O I：
10.1016/j.jmoldx.2012.12.002
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
引用
收藏
页码：280 / 280
页数：1
相关论文
共 50 条
  • [21] Diagnostic Testing for IDH1 and IDH2 Variants in Acute Myeloid Leukemia: An Analgorithmic Approach Using High Resolution Melting Curve Analysis.
    Patel, K. P.
    Barkoh, B. A.
    Chen, Z.
    Ma, D.
    Medeiros, L. J.
    Luthra, R.
    LABORATORY INVESTIGATION, 2011, 91 : 453A - 453A
  • [22] IDH1 and IDH2 mutations in patients with acute myeloid leukemia: Suitable targets for minimal residual disease monitoring?
    Petrova, Lucie
    Vrbacky, Filip
    Lanska, Miriam
    Zavrelova, Alzbeta
    Zak, Pavel
    Hrochova, Katerina
    CLINICAL BIOCHEMISTRY, 2018, 61 : 34 - 39
  • [23] DDPCR SPECIFIC ASSAYS APPLICATION FOR THE MOLECULAR ANALYSIS OF IDH1 AND IDH2 GENES MUTATIONS IN ACUTE MYELOID LEUKEMIA
    Carollo, C.
    Nikitsenka, K.
    Novella, E.
    Tosetto, A.
    HAEMATOLOGICA, 2024, 109 : 88 - 89
  • [24] Prognostic Significance of IDH1 and IDH2 mutations in Older Patients with Primary Cytogenetically Normal Acute Myeloid Leukemia
    Wang, Jinghan
    Ma, Zhixin
    Wang, Qinrong
    Yu, Mengxia
    Yin, Xiufeng
    Li, Xia
    Suo, Shanshan
    Shen, Dan
    Wang, Yungui
    Huang, Xin
    Pan, Hanzhang
    Wang, Huanping
    Chen, Zhimei
    Huang, Jiansong
    Mao, Liping
    Yu, Wenjuan
    Wei, Juying
    Qian, Wenbin
    Mai, Wenyuan
    Meng, Haitao
    Tong, Hongyan
    Chen, Suning
    Marcucci, Guido
    Chen, Saijuan
    Jin, Jie
    BLOOD, 2016, 128 (22)
  • [25] Prevalence and Clinical Effect of IDH1 and IDH2 Mutations Among Cytogenetically Normal Acute Myeloid Leukemia Patients
    Aref, Salah
    Areida, El Sayed Kamel
    Aaal, Mohamed Fathy Abdel
    Adam, Ola Mohamed
    El-Ghonemy, Mohamed Sabry
    El-Baiomy, Mohamed Ali
    Abou Zeid, Tarek
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2015, 15 (09): : 550 - 555
  • [26] Rapid and reliable detection of IDH1 R132 mutations in acute myeloid leukemia using high-resolution melting curve analysis
    Lin, Jiang
    Qian, Jun
    Yao, Dong-Ming
    Li, Yun
    Yang, Jing
    Chen, Qin
    Chai, Hai-yan
    Xiao, Gao-Fei
    Xu, Wen-rong
    CLINICAL BIOCHEMISTRY, 2011, 44 (10-11) : 779 - 783
  • [27] IDH1 and IDH2 mutations in patients with acute myeloid leukemia: Suitable targets for minimal residual disease monitoring? (vol 61, pg 34, 2018)
    Petrova, Lucie
    Vrbacky, Filip
    Lanska, Miriam
    Zavrelova, Alzbeta
    Zak, Pavel
    Hrochova, Katerina
    CLINICAL BIOCHEMISTRY, 2019, 63 : 161 - 161
  • [28] Primary acute myeloid leukemia cells with IDH1 or IDH2 mutations respond to a DOT1L inhibitor in vitro
    Sarkaria, S. M.
    Christopher, M. J.
    Klco, J. M.
    Ley, T. J.
    LEUKEMIA, 2014, 28 (12) : 2403 - 2406
  • [29] IDH1 and IDH2 mutations confer an adverse effect in patients with acute myeloid leukemia lacking the NPM1 mutation
    Yamaguchi, Shunichiro
    Iwanaga, Eisaku
    Tokunaga, Kenji
    Nanri, Tomoko
    Shimomura, Taizo
    Suzushima, Hitoshi
    Mitsuya, Hiroaki
    Asou, Norio
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2014, 92 (06) : 471 - 477
  • [30] IDH1 and IDH2 Mutations Confer An Adverse Effect In Patients With Acute Myeloid Leukemia Lacking The NPM1 Mutation
    Yamaguchi, Shunichiro
    Iwanaga, Eisaku
    Tokunaga, Kenji
    Nanri, Tomoko
    Shimomura, Taizo
    Suzushima, Hitoshi
    Okuno, Yutaka
    Mitsuya, Hiroaki
    Asou, Norio
    BLOOD, 2013, 122 (21)
12345